Masayuki Nagahashi (Kohei Miura)

Years Active: 2021-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Victor Lopez-Lopez, Masayuki Nagahashi, Christoph Kuemmerli, Antonio Capel, Dilmurodjon Eshmuminov, David Ferreras, Alberto Baroja-Mazo, Pedro Cascales-Campos, María Isabel Jiménez-Mascuñán, José Antonio Pons, Maria Isabel Castellon, Francisco Sánchez-Bueno, Ricardo Robles-Campos, Pablo Ramírez
Selecting the Appropriate Downstaging and Bridging Therapies for Hepatocellular Carcinoma: What Is the Role of Transarterial Radioembolization? A Pooled Analysis. Cancers 15 (7) (2023)
Kohei Miura, Masayuki Nagahashi, Pankaj Prasoon, Yuki Hirose, Takashi Kobayashi, Jun Sakata, Manabu Abe, Kenji Sakimura, Yasunobu Matsuda, Ali L Butash, Eriko Katsuta, Kazuaki Takabe, Toshifumi Wakai
Dysregulation of sphingolipid metabolic enzymes leads to high levels of sphingosine-1-phosphate and ceramide in human hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 51 (5) (2021)

Masayuki Nagahashi.css-eqlu8i{font-size:small;padding-left:4px;} (Kohei Miura)